Odonate Therapeutics, Inc., a pharmaceutical company, develops therapeutics for the treatment of cancer. It is developing tesetaxel, an orally administered chemotherapy agent, which is in Phase III clinical study for patients with metastatic breast cancer. The company was founded in 2013 and is based in New York, New York.
Date |
For |
Estimate |
Reported |
Surprise |
surprise % |
2023-01-04 |
2022-09 |
0 |
N/A |
N/A |
N/A |
2022-10-04 |
2022-06 |
0 |
N/A |
N/A |
N/A |
2022-07-01 |
2022-03 |
0 |
N/A |
N/A |
N/A |
2022-04-05 |
2021-12 |
0 |
N/A |
N/A |
N/A |
2021-11-10 |
2021-09 |
0 |
N/A |
N/A |
N/A |
2021-07-27 |
2021-06 |
0 |
N/A |
N/A |
N/A |
Date |
Firm |
Action |
From |
To |
2019-08-27 |
Empire Asset Management |
Upgrade |
|
Sell |
2018-01-02 |
Goldman Sachs |
Upgrade |
|
Neutral |
2018-01-02 |
Cowen & Co. |
Upgrade |
|
Outperform |
2018-01-02 |
Jefferies |
Upgrade |
|
Buy |
Date |
Name |
Relation |
Quantity |
Description |
2020-12-29 |
BOXER CAPITAL L L C |
Beneficial Owner of more than 10% of a Class of Security |
0.00 |
Purchase |
2020-12-29 |
DAVIS AARON I |
Director and Beneficial Owner of more than 10% of a Class of Security |
0.00 |
Purchase |
2021-03-14 |
HEARNE MICHAEL S. |
Chief Financial Officer |
15.52M |
Stock Award(Grant) |
2020-12-28 |
JOHNSON CRAIG A |
Director |
3.00K |
Purchase |
2020-11-29 |
LEMKEY JOHN G |
Chief Operating Officer |
15.24M |
Stock Award(Grant) |
2021-03-14 |
O'CONNELL JOSEPH P |
Officer |
3.61K |
Stock Award(Grant) |
Institution Ownership
...
Report Date |
Organization |
Position |
Value |
Percentage |
2021-09-29 |
Tang Capital Management, LLC |
15.51M |
45.15M |
40.31% |
2021-09-29 |
Boxer Capital, LLC |
5.61M |
16.32M |
14.57% |
2021-09-29 |
EcoR1 Capital, LLC |
3.73M |
10.85M |
9.68% |
2021-09-29 |
Ikarian Capital, LLC |
1.84M |
5.36M |
4.78% |
2021-09-29 |
Vanguard Group, Inc. (The) |
962.20K |
2.80M |
2.50% |
2021-09-29 |
Blackrock Inc. |
731.50K |
2.13M |
1.90% |
Report Date |
Organization |
Position |
Value |
Percentage |
2021-09-29 |
Vanguard Total Stock Market Index Fund |
449.60K |
1.31M |
1.17% |
2021-09-29 |
Vanguard Extended Market Index Fund |
319.90K |
930.91K |
0.83% |
2021-10-30 |
iShares NASDAQ Biotechnology ETF |
305.63K |
938.27K |
0.79% |
2021-09-29 |
Vanguard Horizon Fund-Strategic Small-Cap Equity Fund |
161.72K |
470.61K |
0.42% |
2021-10-30 |
Fidelity Extended Market Index Fund |
160.57K |
492.95K |
0.42% |
2021-08-30 |
Schwab Strategic Tr-Schwab U.S. Small Cap ETF |
81.26K |
281.98K |
0.21% |